The impact of age group in breast cancer survival outcome according to neoadjuvant treatment response: A matched case

The impact of age group in breast cancer survival outcome according to neoadjuvant treatment response: A matched case–control study

Published:2021-11-25 Issue: Volume: Page:
ISSN:1607-551X
Container-title:The Kaohsiung Journal of Medical Sciences
language:en
Short-container-title:The Kaohsiung Journal of Medical Sciences

Author:

Li Chung‐Liang¹^ORCID,Wu Cheng‐Che¹,Kan Jung‐Yu¹,Chen Fang‐Ming²³⁴,Hou Ming‐Feng¹⁵^ORCID,Chuang Chieh‐Han¹,Huang Hsin‐I⁶,Ou‐Yang Fu¹

Affiliation:

1. Division of Breast Oncology and Surgery, Department of Surgery Kaohsiung Medical University Hospital, Kaohsiung Medical University Kaohsiung Taiwan

2. Department of Surgery Kaohsiung Municipal Ta‐Tung Hospital Kaohsiung Taiwan

3. Cancer Center Kaohsiung Municipal Ta‐Tung Hospital Kaohsiung Taiwan

4. Department of Surgery, Faculty of Medicine, College of Medicine Kaohsiung Medical University Kaohsiung Taiwan

5. Department of Biomedical Science and Environmental Biology College of Life Science, Kaohsiung Medical University Kaohsiung Taiwan

6. Center of Cancer Program Development E‐Da Cancer Hospital, I‐Shou University Kaohsiung Taiwan

Funder

Kaohsiung Medical University Chung-Ho Memorial Hospital

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/kjm2.12475

Reference31 articles.

1. Impact of aging on the biology of breast cancer

2. Impact of age on elderly patients with oral cancer

3. Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial

4. Clinicopathological features of young versus older patients with breast cancer at a single Pakistani institution and a comparison with a national US database;Zeeshan S;J Glob Oncol,2019

5. Updated survival analysis after a median follow‐up of 12 years of an anthracycline‐containing adjuvant prospective multicentre, randomised phase III trial on dose‐dense chemotherapy in primary node‐positive, high‐risk breast cancer patients;Reinisch M;Breast Care (Basel),2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor Necrosis Factor-alpha Levels as a Predictor of Clinical Neoadjuvant Chemotherapy Response in a Luminal-type Locally Advance Breast Cancer in Surabaya, Indonesia;Biomolecular and Health Science Journal;2024-01

2. Predictors of Complete Pathological Response with Chemoimmunotherapy in Triple-Negative Breast Cancer: A Meta-Analysis;Onco;2023-12-28

3. Tumour necrosis factor-alpha levels as predictor factor on clinical response of anthracycline-based neoadjuvant chemotherapy in locally advance breast cancer patients: experimental research;Annals of Medicine & Surgery;2023-04